×
0 0 0.0216216216216216 0.0108108108108108 0.00540540540540541 -0.0108108108108108 -0.104 -0.0596216216216217
Stockreport

SCYNEXIS to Discuss ECCMID 2019 Clinical Data, Including Successful Case Studies in Candida auris and Other Difficult-to-Treat Infections, on Conference Call

SCYNEXIS, Inc (SCYX)  More Company Research Source: PR Newswire
Last scynexis, inc earnings: 11/13 09:05 am Check Earnings Report
US:NASDAQ Investor Relations: ir.scynexis.com/investor-relations
PDF JERSEY CITY, N.J., April 15, 2019 /PRNewswire/ -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced results showing evidence of activity of the company's lead product candidate, ibrexafungerp, against fungal infections in multiple settings and indications. These include case studies showing treatment with oral ibrexafungerp resulting in full clearance of Candida auris infections. The findings were described in one oral presentation and five poster presentations at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 13-16, 2019, in Amsterdam, Netherlands."We are encouraged by the data shared at ECCMID 2019 and ibrexafungerp's potential to be a new treatment in the fight against difficult-to-treat and resistant fungal infections," said David Angulo, M.D., Chief Medical Officer of SCYNEXIS. "This additional evidence of clinical activit [Read more]

IMPACT SNAPSHOT EVENT TIME: SCYX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
SCYX alerts
from News Quantified
Opt-in for
SCYX alerts

from News Quantified
Opt-in for
SCYX alerts

from News Quantified